Brief: NanoCarrier commences phase I/II clinical trial for treatment of soft tissue sarcomas in U.S

Nano Holdings

05/01/2017 03:11

Jan 5 (Reuters) - NanoCarrier Co Ltd    4571.T : 
     
     
    * Says it commenced phase I/II clinical trial for treatment 
of soft tissue sarcomas in the United States  
     
     
    Source text in Japanese:https://goo.gl/huQUEn 
    Further company coverage: 4571.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))